Affymax's Unattributed VC Round

Affymax raised a round of funding on April 19, 2004.

Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. The companys product candidate, Hematide, is curre…

Articles about Affymax's Unattributed VC Round: